Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Celecoxib in Mild Thyroid Eye Disease
NCT02845336Phase 2Terminated
- Sponsor
- Johns Hopkins University
- Start
- Mar 2017
- Primary completion
- Jun 2019
- Countries
- 1
01
Overview
A Phase 2 trial of celecoxib oral solution in thyroid eye disease (TED), sponsored by Johns Hopkins University. Started Mar 2017; status: terminated.
02
Drugs
celecoxib oral solution
03
Conditions
thyroid eye disease (TED)
Beyond the preview
Go deeper on NCT02845336.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02845336.